Optical Communications News

RSS
Molex Expands Fiber Optic Technology Platform with Oplink Acquisition

Molex Expands Fiber Optic Technology Platform with Oplink Acquisition

Cosemi to Participate in OFC 2015's Market Watch Panel Discussion

Cosemi to Participate in OFC 2015's Market Watch Panel Discussion

Tektronix Introduces Optical Test Solution with Signal Sensitivity Sufficient for 100GBASE-SR4 Specification

Tektronix Introduces Optical Test Solution with Signal Sensitivity Sufficient for 100GBASE-SR4 Specification

OFC 2015: Coriant to Showcase Latest Innovations in Packet Optical Transport Solutions

OFC 2015: Coriant to Showcase Latest Innovations in Packet Optical Transport Solutions

Applied Optoelectronics Introduces New 100Gbps Optical Modules for Datacenter Applications

Applied Optoelectronics Introduces New 100Gbps Optical Modules for Datacenter Applications

OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link

OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link

OFC 2015: SCHOTT to Showcase New TEC TO Package for Tele- and Data Communication Applications

OFC 2015: SCHOTT to Showcase New TEC TO Package for Tele- and Data Communication Applications

ADVA Optical Networking’s FSP 150 Carrier Ethernet Portfolio to Spearhead NFV Strategy

ADVA Optical Networking’s FSP 150 Carrier Ethernet Portfolio to Spearhead NFV Strategy

Global Free-Space Optical Communications Market Expected to Reach $501.1 Million in 2019

Global Free-Space Optical Communications Market Expected to Reach $501.1 Million in 2019

Oclaro Announces Sampling of New Dual Micro-ITLA with DS-DBR Wideband Tunable Laser Technology

Oclaro Announces Sampling of New Dual Micro-ITLA with DS-DBR Wideband Tunable Laser Technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.